Christopher Berger

Christopher Berger has a diverse work experience in the biopharmaceutical industry. Christopher began their career at Allergan in 2003, where they held various roles in analytical development and biologics development. From 2011 to 2015, they served as a Manager and Supervisor in these departments. In 2015, they joined Peregrine Pharmaceuticals as a Senior Manager responsible for stability and method transfer. Later in the same year, they started working at Avid Bioservices, where they held roles of increasing responsibility, including Associate Director and Director of Quality Control. In 2019, they became the Senior Director of Quality Control and Analytical Development, and in 2022, they were promoted to the position of Executive Director, Quality, Viral Vector.

Christopher Berger received their Master of Science degree in Chemistry from California State University, Fullerton in 2004. Christopher later pursued their Master of Business Administration (MBA) degree from Pepperdine Graziadio Business School from 2006 to 2008.